Helping Employees Lose Pounds (HELP)

April 14, 2017 updated by: Jeffrey T. Kullgren, University of Michigan

Translating Insights From Behavioral Economics and Self-Determination Theory to Promote Sustained Weight Loss Among Obese Employees

This study will evaluate the effectiveness of financial incentives and messaging tailored to individual goals and aspirations to promote and sustain weight loss. This is a 2-arm randomized controlled trial that will recruit eligible employees at a large university to participate in a 3-month weight loss program, followed by a 3-month follow-up period. The primary outcome will be change in autonomous motivation for weight loss.

The study hypothesis is that intervention group participants will have a greater increase in autonomous motivation for weight loss than participants in the control group at 12 weeks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Interested in losing weight
  • Body Mass Index between 30 and 40 kg/m2
  • Have wireless internet at home
  • Have Android or iOS smart device
  • Willing to record themselves weighing in on a scale or let a family member record them weighing in on a scale

Exclusion Criteria:

  • Pregnant or lactating, or intending to become pregnant in the next 6 months
  • Taking medication (other than metformin) for diabetes to control blood sugar
  • Having a serious psychiatric diagnosis, unstable medical conditions or experienced a heart attack or stroke in the past 6 months
  • Having a history of drug or alcohol abuse or addiction to prescription medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Weekly Incentive
Participants in the Weekly Incentive arm will be asked to weigh in each week during a 12 week intervention period. They will receive tailored messages and have an opportunity to win a financial reward each week they meet their weight loss goal. Participants will be asked to complete a final weight measurement at week 24.
The tailored incentives intervention aims to assess the impact of tailored messaging and financial incentives on weight loss among obese employees.
No Intervention: Weekly Weigh-In
Participants in the Weekly Weigh-In arm will be asked to weigh in each week during a 12 week intervention period. Participants will be asked to complete a final weight measurement at week 24.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in autonomous motivation as measured by the Treatment Self-Regulation Questionnaire
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in weight as measured by participant weight measurements using Withings scales
Time Frame: 12 weeks and 24 weeks
12 weeks and 24 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Change in autonomous motivation as measured by the Treatment Self-Regulation Questionnaire
Time Frame: 24 weeks
24 weeks
Change in physical activity as measured by the short form of the International Physical Activity Questionnaire
Time Frame: 12 weeks and 24 weeks
12 weeks and 24 weeks
Change in eating behaviors as measured by the Three Factor Eating Questionnaire
Time Frame: 12 weeks and 24 weeks
12 weeks and 24 weeks
Change in participation in weight-related wellness programs as measured by responses to the question "In the past 3 months, have you participated in any health and wellness programs?"
Time Frame: 12 weeks and 24 weeks
12 weeks and 24 weeks
Change in self-efficacy to lose weight as measured by the Perceived Competence Scale
Time Frame: 12 weeks and 24 weeks
12 weeks and 24 weeks
Change in stage of change for weight loss as measured by responses to the questions "Are you currently trying to lose weight?" and "Do you intend to try to lose weight in the near future?"
Time Frame: 12 and 24 weeks
12 and 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey T Kullgren, MD,MS,MPH, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2016

Primary Completion (Actual)

January 4, 2017

Study Completion (Actual)

April 7, 2017

Study Registration Dates

First Submitted

July 27, 2016

First Submitted That Met QC Criteria

July 29, 2016

First Posted (Estimate)

August 3, 2016

Study Record Updates

Last Update Posted (Actual)

April 18, 2017

Last Update Submitted That Met QC Criteria

April 14, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HUM00107647

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe